May
TL;DR: In the best-known clinical study of sun and facial aging, UV exposure accounted for roughly 80% of the visible aging differences among 298 same-age women. The mechanism runs on enzymes: each UV dose switches on collagen-degrading MMPs for days afterward, even without a burn. Daily sunscreen produced 24% less measurable skin aging in a randomized trial. For repair, prescription tretinoin carries decades of randomized evidence, with vitamin C and laser resurfacing as supporting options. Photoaging responds to treatment, however preventing it is far easier than reversing it.
How much of facial aging is actually the sun? In the best-known clinical study, UV exposure accounted for roughly 80% of visible facial aging differences: 80.3% to be exact. That figure comes from a model-derived analysis of 298 Caucasian women led by a L’Oréal-affiliated researcher (Clinical, Cosmetic and Investigational Dermatology, 2013). In my experience treating Guelph patients, I see the pattern behind that number weekly. A face and forearms can look a decade older than the skin of the inner arm, which stays close to its chronological age. That gap is photoaging, and it’s the part of aging you control most. Here’s what UV actually does to skin, and which photoaging treatments have real evidence behind them.
Key Takeaways
- UV exposure accounted for roughly 80% of visible facial aging differences in a 298-woman study (model-derived; L’Oréal-affiliated) (Clinical, Cosmetic and Investigational Dermatology, 2013).
- A single UV exposure induces collagen-degrading enzymes; exposure every two days kept collagenase maximally elevated for seven days (New England Journal of Medicine, 1997).
- Daily broad-spectrum sunscreen produced 24% less measurable skin aging over 4.5 years in a randomized trial (Annals of Internal Medicine, 2013).
- Prescription tretinoin improved both fine and coarse wrinkles across 8 randomized trials totalling 1,361 participants (Dermatology Practical & Conceptual, 2025).
Photoaging is premature skin aging caused by cumulative ultraviolet exposure, layered on top of normal chronological aging. In fact, it’s not a minor contributor. In the best-known clinical study, UV exposure accounted for roughly 80% of the visible facial aging differences among 298 Caucasian women, a model-derived estimate from a L’Oréal-affiliated team (Clinical, Cosmetic and Investigational Dermatology, 2013).
The same analysis found something stranger: a 2% change in the sun-damage parameter shifted apparent age by roughly three years. Consequently, small differences in lifetime exposure read as big differences in the mirror. In our experience, photoaging shows up as rough texture, uneven pigment, fine lines, and sallow tone — changes we assess on our sun damage service page and treat as Dimension 4 of my 5-Dimension Skin Plan™.
Through enzymes, and fast. A single UV exposure, even below sunburn dose, induces matrix metalloproteinases (MMPs), the enzymes that degrade collagen (New England Journal of Medicine, 1997). In fact, in the same research, exposure every two days kept collagenase maximally elevated for seven straight days.
Consequently, each tan or burn triggers days of collagen breakdown, and the damage compounds quietly between visible burns. Ever heard a tan called “healthy”? What I tell patients is blunt: biochemically, it’s a damage response with a week-long enzymatic tail.
Meanwhile, the same study contained a preview of repair: pretreating skin with tretinoin, a prescription retinoid, inhibited that MMP induction by 70-80%. More on tretinoin below, because prevention and repair turn out to share biology.
Yes, and it’s been tested in a randomized trial. Participants assigned to daily broad-spectrum sunscreen showed 24% less measurable skin aging after 4.5 years than those using sunscreen at their own discretion, in Australia’s Nambour trial (Annals of Internal Medicine, 2013). One honest caveat: the endpoint was microtopography of hand skin, not facial photographs.
Meanwhile, the cancer data from the same cohort points the same way. At roughly ten years, the daily-sunscreen group recorded 3 invasive melanomas versus 11 with discretionary use, a hazard ratio of 0.27 (Journal of Clinical Oncology, 2011). Case counts were small and overall significance borderline, so I present it as encouraging rather than settled. However, the direction of both findings favours the same boring habit: daily use.
Partly because we invented the warning and stopped reading it. The UV Index was created by Environment Canada scientists in 1992 and adopted internationally by the WMO and WHO in 1994 (Canadian Journal of Public Health). Meanwhile, 33% of Canadian adults reported a sunburn within the past year (Statistics Canada, Health Reports, 2017).
In fact, the same national data shows only 45% of us apply sunscreen to the face when heading into 30 or more minutes of sun. And exposure isn’t limited to beach days. In a study of 29 automobiles, windshields blocked about 96% of UVA on average, however side windows averaged only 71%, ranging from 44% to 96% (JAMA Ophthalmology, 2016).
That gap shows up on real skin. In one US series, 74% of melanoma in situ cases arose on the left side of the body, the driver’s side (Journal of the American Academy of Dermatology, 2010). Canada seats drivers on the left too. If you’ve logged decades of commutes or outdoor summers, periodic checks matter. In my practice, that’s exactly what our mole mapping and skin cancer screening program is for.
Prescription tretinoin carries the longest randomized-trial record. A 2025 meta-analysis of 8 randomized trials totalling 1,361 participants confirmed improvement in both fine and coarse wrinkles (Dermatology Practical & Conceptual, 2025). It also found tripled odds of irritation (OR 3.14) and publication bias in the fine-wrinkle studies, so I calibrate expectations before anyone starts.
Here’s how I rank the evidence for repair:
Meanwhile, sunscreen sits underneath everything. Repairing collagen while skipping daily protection is bailing water with the tap running.
Partially. Prescription tretinoin improved both fine and coarse wrinkles across 8 randomized trials totalling 1,361 participants (Dermatology Practical & Conceptual, 2025), and fractional CO2 reduced cheek wrinkle depth up to 58.3% in one uncontrolled study. However, no treatment returns skin to its unexposed baseline, so prevention stays part of every plan.
Daily use, not occasional use. In the randomized Nambour trial, daily broad-spectrum sunscreen produced 24% less measurable skin aging after 4.5 years than discretionary use (Annals of Internal Medicine, 2013). Meanwhile, only 45% of Canadian adults apply facial sunscreen before 30-plus minutes of sun (Statistics Canada, 2017).
Yes, especially on the left. Windshields blocked about 96% of UVA in testing, however side windows averaged only 71%, with some blocking as little as 44% (JAMA Ophthalmology, 2016). In fact, one US series found 74% of melanoma in situ cases on the left, the driver’s side (JAAD, 2010).
No. A tan is a damage signal, not a shield. Controlled human research found UV exposure every two days kept collagen-degrading collagenase maximally elevated for seven days (New England Journal of Medicine, 1997). Consequently, “building a base” means running collagen breakdown continuously for weeks before your vacation even begins.
The randomized evidence points that way. Ten-year follow-up of the Nambour trial recorded 3 invasive melanomas with daily sunscreen versus 11 with discretionary use, a hazard ratio of 0.27, though counts were small and significance borderline (Journal of Clinical Oncology, 2011). Regular professional skin checks remain important either way.
If your skin shows more sun than birthdays, that’s something I assess and treat weekly in our Guelph clinic. We’ll evaluate your photoaging alongside the other dimensions of facial aging, discuss prescription and procedural options honestly, and build daily prevention into whatever we plan. Request a consultation and bring your questions. However you decide to proceed, you’ll leave with a plan you can actually follow.
Medically reviewed by Dr. Dusan Sajic, MD, PhD — dermatologist, deRMA Skin Institute, Guelph, ON.
1. Flament F et al. “Effect of the sun on visible clinical signs of aging in Caucasian skin.” Clinical, Cosmetic and Investigational Dermatology, 2013 (298 women; model-derived; L’Oréal-affiliated). https://pmc.ncbi.nlm.nih.gov/articles/PMC3790843/ 2. Fisher GJ et al. “Pathophysiology of premature skin aging induced by ultraviolet light.” New England Journal of Medicine, 1997. https://pubmed.ncbi.nlm.nih.gov/9358139/ 3. Hughes MC et al. “Sunscreen and prevention of skin aging: a randomized trial” (Nambour trial; hand-skin microtopography endpoint). Annals of Internal Medicine, 2013. https://pubmed.ncbi.nlm.nih.gov/23732711/ 4. Green AC et al. “Reduced melanoma after regular sunscreen use: randomized trial follow-up.” Journal of Clinical Oncology, 2011. https://pubmed.ncbi.nlm.nih.gov/21135266/ 5. Fioletov V et al. The UV Index: definition, distribution and factors affecting it. Canadian Journal of Public Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC6974160/ 6. Statistics Canada. Sun exposure and protection behaviours among Canadian adults. Health Reports, 2017. https://www150.statcan.gc.ca/n1/pub/82-003-x/2017005/article/14792-eng.htm 7. Weiss JS et al. “Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled study.” JAMA, 1988. https://jamanetwork.com/journals/jama/fullarticle/372295 8. Kang S et al. Two-year randomized trial of tretinoin 0.05% in moderate-to-severe photodamage (204 patients). American Journal of Clinical Dermatology, 2005. https://link.springer.com/article/10.2165/00128071-200506040-00005 9. Meta-analysis of 8 tretinoin randomized trials (1,361 participants; irritation OR 3.14; publication bias noted). Dermatology Practical & Conceptual, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12615114/ 10. Humbert PG et al. Topical 5% vitamin C versus vehicle for photoaged skin: six-month double-blind trial. Experimental Dermatology, 2003. https://onlinelibrary.wiley.com/doi/abs/10.1034/j.1600-0625.2003.00008.x 11. Kohl E et al. Fractional CO2 laser resurfacing: prospective profilometric study (uncontrolled). British Journal of Dermatology, 2014. https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.12807 12. Boxer Wachler BS. “Assessment of levels of ultraviolet A light protection in automobile windshields and side windows.” JAMA Ophthalmology, 2016. https://pubmed.ncbi.nlm.nih.gov/27258091/ 13. Butler ST, Fosko SW. Increased prevalence of left-sided skin cancers (melanoma in situ 74% left-sided). Journal of the American Academy of Dermatology, 2010. https://pubmed.ncbi.nlm.nih.gov/20226568/
Dusan Sajic, MD, PhD
Richard Backstein, MD
Sonja Sajic, CCPA
Toni Alberto, CCPA
With more than 20 years of experience, deRMA Skin Institute strive to offer patients the most advanced treatments available to keep their skin healthy and looking its best. Board Certified Dermatologist, Dusan Sajic, MD, PhD, board-certified Plastic and Reconstructive Surgeon, Richard Backstein, MD, FRCSC, Sonja Sajic, CCPA, and Toni Alberto CCPA are committed to providing state-of-the-art medical, surgical and cosmetic treatments to all patients in Guelph, Cambridge, Kitchener, Hamilton, Milton, and surrounding areas.
Fields marked * are required
If you are an existing patient inquiring about appointments and services, please contact
Guelph Cosmetic Department: (888) 803-3762 cosmetic@dermaskininstitute.com
Guelph Medical Department: (519) 836-8558 patientcare@dermaskininstitute.com